Oncosil Medical Ltd has released a press release.
OncoSil presents clinical data at ESMO World Congress
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- OncoSil files for TGA registration
- OncoSil receives Singapore regulatory approval
- Allotment of Securities under Institutional Placement
- Proposed issue of Securities - OSL
- Oncosil breakthrough device receives CE Marking approval
Later from OncoSil Medical
- HDE filing submitted in US for Bile Duct Cancer treatment
- Preliminary Final Report - Appendix 4E Announcement
- OncoSil receives Malaysian regulatory approval
- Investor Update
- Receipt of $2.8m R&D Tax Incentive Refund
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical